| mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.05 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.06 |
| mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.06 |
| mRNA |
THZ-2-102-1 |
GDSC1000 |
pan-cancer |
AAC |
0.063 |
0.06 |
| mRNA |
MG-132 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.06 |
| mRNA |
PIK-93 |
GDSC1000 |
pan-cancer |
AAC |
0.059 |
0.06 |
| mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.06 |
| mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.06 |
| mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.06 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.06 |